Jakafi Ruxolitinib — Medica
11 indications indexed for this drug.
- Accelerated Or Blast Phase Myeloproliferative NeoplasmView coverage criteria
- Acute Lymphoblastic LeukemiaView coverage criteria
- Atypical Chronic Myeloid LeukemiaView coverage criteria
- Chronic Myelomonocytic Leukemia 2View coverage criteria
- Essential ThrombocythemiaView coverage criteria
- Graft Versus Host Disease AcuteView coverage criteria
- Graft Versus Host Disease ChronicView coverage criteria
- Myelofibrosis Including Primary Mf Post Polycythemia Vera MfView coverage criteria
- Myeloid Or Lymphoid Neoplasms With Eosinophilia And Jak2 ReaView coverage criteria
- Polycythemia VeraView coverage criteria
- T Cell LymphomaView coverage criteria